Insufficient scRNA-seq data for expression of KCTD21 at single-cell level.
Insufficient scRNA-seq data for expression of KCTD21 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1023.96 | 226 / 226 | 100% | 14.04 | 406 / 406 |
brain | 100% | 898.77 | 2641 / 2642 | 100% | 17.38 | 705 / 705 |
thymus | 100% | 878.77 | 653 / 653 | 100% | 14.91 | 604 / 605 |
prostate | 100% | 519.04 | 245 / 245 | 100% | 7.59 | 501 / 502 |
breast | 100% | 556.16 | 458 / 459 | 100% | 17.44 | 1117 / 1118 |
ovary | 100% | 816.95 | 180 / 180 | 99% | 9.58 | 427 / 430 |
uterus | 100% | 500.04 | 170 / 170 | 99% | 7.80 | 455 / 459 |
intestine | 100% | 677.96 | 965 / 966 | 99% | 6.31 | 522 / 527 |
esophagus | 100% | 833.77 | 1445 / 1445 | 99% | 7.10 | 181 / 183 |
bladder | 100% | 792.24 | 21 / 21 | 99% | 8.06 | 498 / 504 |
adrenal gland | 100% | 1586.91 | 258 / 258 | 99% | 10.19 | 227 / 230 |
lung | 99% | 554.45 | 570 / 578 | 99% | 8.84 | 1147 / 1155 |
kidney | 100% | 454.26 | 89 / 89 | 97% | 5.57 | 873 / 901 |
stomach | 96% | 413.19 | 345 / 359 | 99% | 5.87 | 283 / 286 |
skin | 94% | 416.18 | 1700 / 1809 | 100% | 12.75 | 471 / 472 |
pancreas | 91% | 243.15 | 299 / 328 | 99% | 9.12 | 176 / 178 |
blood vessel | 100% | 900.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 11.83 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.17 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.05 | 1 / 1 |
adipose | 100% | 622.19 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 511.10 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 385.97 | 832 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 391.64 | 747 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 677.50 | 789 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0042802 | Molecular function | identical protein binding |
GO_0097602 | Molecular function | cullin family protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | KCTD21 |
Protein name | Potassium channel tetramerization domain containing 21 BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21) |
Synonyms | |
Description | FUNCTION: Probable substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex mediating the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes the ubiquitination of HDAC1. Can function as antagonist of the Hedgehog pathway by affecting the nuclear transfer of transcription factor GLI1; the function probably occurs via HDAC1 down-regulation, keeping GLI1 acetylated and inactive. Inhibits cell growth and tumorigenicity of medulloblastoma (MDB) . . |
Accessions | ENST00000529350.1 ENST00000528776.1 E9PRT1 E9PMS5 E9PM10 ENST00000525447.1 E9PK99 ENST00000526208.5 ENST00000530018.5 Q4G0X4 ENST00000340067.4 E9PJJ5 |